ÂÜÀòÂÒÂ×

Christopher Martin is a seasoned professional in the pharmaceutical and scientific research sectors with extensive experience in drug manufacturing and development. Currently serving as Vice President of Manufacturing at Parabilis Medicines since June 2024, Christopher previously held the position of Senior Director of Production and Process Development at Bachem, overseeing GMP drug manufacturing, process development, and commercial drug manufacturing from February 2016 to June 2024. Earlier roles include Director of Production API and Senior Group Leader API, demonstrating strong leadership in various manufacturing settings. Academic credentials include a Ph.D. from Freie Universität Berlin and a Diplom in Chemistry from The University of Freiburg, complemented by postdoctoral research fellowships at prestigious institutes.